AMICUS THERAPEUTICS, INC.
Biotechnology · Healthcare
Board Member
Equibles does not estimate personal net worth.
Earlier roles on record: Board Member at AMICUS THERAPEUTICS, INC. until April 27, 2026. AMICUS THERAPEUTICS, INC. reported in an 8-K filed April 27, 2026 that Margaret G. McGlynn resigned as director, effective April 27, 2026.
“In connection with the consummation of the Merger, as of the Effective Time, each of the directors of the Company (Michael G. Raab, Bradley L. Campbell, Lynn D. Bleil, Michael A. Kelly, Margaret G. McGlynn, Eiry W. Roberts, M.D., Glenn P. Sblendorio, Craig A. Wheeler and Burke W. Whitman) resigned and ceased to be directors of the Company and members of any committee of the Company's board of directors.”
AMICUS THERAPEUTICS, INC.
Board Member
Proxy statement
Start not stated–2026-04-27
AMICUS THERAPEUTICS, INC.
Biotechnology · Healthcare
Board Member